MIH
CANF

Meitav Investment House’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Meitav Investment House’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-170
Closed -$103K – 446
2019
Q2 		$103K Hold
170
– – 0.01% 417
2019
Q1 		$448K Buy
170
+14
+9% +$48.9K 0.03% 255
2018
Q4 		$518K Buy
156
+33
+27% +$127K 0.03% 198
2018
Q3 		$488K Buy
+123
New +$461K 0.02% 322
2018
Q2 		– Sell
-81
Closed -$352K – 429
2018
Q1 		$352K Buy
81
+29
+56% +$160K 0.02% 276
2017
Q4 		$240K Buy
+52
New +$238K 0.01% 186

Other funds holding CANF

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return